NCT01005121 arm group 89b62ca0482f6f3067f88ee6eff8ce7c [clinicaltrials_resource:NCT01005121/arm-group/89b62ca0482f6f3067f88ee6eff8ce7c]
arm group [clinicaltrials_vocabulary:arm-group]
NCT01005121 arm group 89b62ca0482f6f3067f88ee6eff8ce7c [clinicaltrials_resource:NCT01005121/arm-group/89b62ca0482f6f3067f88ee6eff8ce7c]
Bio2RDF identifier
NCT01005121/arm-group/89b62ca0482f6f3067f88ee6eff8ce7c
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... b62ca0482f6f3067f88ee6eff8ce7c
description [clinicaltrials_vocabulary:description]
patients will receive 2 mg of colchicine daily
identifier
clinicaltrials_resource:NCT01005121/arm-group/89b62ca0482f6f3067f88ee6eff8ce7c
title
NCT01005121 arm group 89b62ca0482f6f3067f88ee6eff8ce7c
@en
type
label
NCT01005121 arm group 89b62ca0 ...... 62ca0482f6f3067f88ee6eff8ce7c]
@en